References
- Miller G J, Miller N E, Ashcroft M T. Inverse relationship in Jamaica between plasma highdensity lipoprotein cholesterol concentration and coronary heart-disease risk as predicted by multiple risk-factor status. Clin Sci Mol Med 1976; 51: 475
- Gordon T, Castelli W P, Hjortland M C, Kannel W B. The prediction of coronary heart disease by high density and other lipoproteins: An historical perspective. Hyperlipidaemia, diagnosis and therapy, B M Rifkind, R I Levy. Grune and Stratton, New York 1977; 71–8
- Brewer H B, Jr, Schaefer E J, Osborne J C, Jr, Zech L A. High density lipoproteins: an overview. Proceedings of the high density lipoprotein methodology workshop. DHEW Publ., Bethesda, Md 1979; 29–42, No. 79
- Kostner G M, Patsch J R, Sailer S, Braunsteiner H, Holasek A. Polypeptide distribution of the main lipoprotein density classes separated from human plasma by rate zonal ultracentrifugation. Eur J Biochem 1974; 45: 611–21
- Cheung M C, Albers J J. Distribution of cholesterol and apolipoprotein A-I and A-II in human high density lipoprotein subfractions separated by CsCl equilibrium gradient centrifugation: evidence for HDL subpopulations with differing AI/AII molar ratios. J Lipid Res 1979; 20: 200–7
- Albers J J, Aladjem F. Precipitation of 125I labelled lipoproteins with specific polypeptide antisera. Evidence for two populations with differing polypeptide composition in human high density lipoproteins. Biochemistry 1971; 10: 3436–42
- Ehnholm C, Huttunen J K, Pietinen P, et al. Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease. N Engl J Med 1982; 307: 850–5
- Atmeh R F, Shepherd J, Packard C J. Subpopulations of apolipoprotein A-I in human high-density lipoproteins. Their metabolic properties and response to drug therapy. Biochim Biophys Acta 1983; 751: 175–88
- Fager G, Wiklund O, Olofsson S O, Wilhelmsen L, Bondjers G. Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction. Arteriosclerosis 1981; 1: 273–9
- Albers J J, Cheung M C, Hazzard W R. High-density lipoproteins in myocardial infarction survivors. Metabolism 1978; 27: 479–85
- Maciejko J J, Holmes D R, Kottke B A, Zinsmeister A R, Dinh D M, Mao S JT. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med 1983; 309: 385–9
- Noma A, Yokosuka T, Kitamura K. Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease. Atherosclerosis 1983; 49: 1–7
- Fager G, Wiklund O, Olofsson S-O, Norfeldt P, Verdin A, Bondjers G. Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factors. Artery 1979; 6: 188–204
- Steinberg K K, Cooper G R, Graiser S R, Rosseneu M. Some considerations of methodology and standardization of apolipoproteins A-I immuno-assay. Clin Chem 1983; 29: 415–26
- Funke H, Assmann G. Influence of triglyceriderich lipoproteins on nephelometry of apolipoprotein A-I. Clin Chem 1982; 28: 1153–8
- Lopes-Virella M FL, Virella G, Evans G, et al. Immunonephelometric assay of human apo-A-I. Clin Chem 1980; 26: 1205–8
- Weinstock N, Batholome M, Seidel D. Determination of apolipoprotein A-I by kinetic nephelometry. Biochim Biophys Acta 1981; 663: 279–88
- Rosseneu M, Vercaemst R, Vinaimont N, et al. Quantitative determination of human plasma apolipoprotein A-I by laser immunonephelometry. Clin Chem 1981; 27: 856–9
- Shapiro D, Ballantyne F C, Shepherd J. Comparison of immunonephelometry and electroimmunoassay for estimation of plasma apolipoprotein A-I. Clin Chim Acta 1980; 103: 7–13
- Fievet-Desreumaux C, Dedonder-Decoopman E, Dewasilly P, et al. Immunochemical determination of human apolipoprotein A-I by laser nephelometry. Clin Chim Acta 1980; 107: 145–148
- De Backer G, Rosseneu M, Deslypere J P. Discrimination value of lipids and apoproteins in coronary heart disease. Atherosclerosis 1982; 42: 197–203
- Albers J J, Cheung M C. Radial immunodiffusion assay of lipoproteins and apoproteins: application to high density lipoproteins. Proceedings of the high density lipoprotein methodology workshop. DHEW Publ., Bethesda, Md 1979; 29–42, No 79
- Brown W V, Levy R I, Fredrickson D S. Studies of the proteins in human very low density lipoproteins. J Biol Chem 1969; 244: 5687–4
- Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5
- Reisfeld R A, Small P A, Jr. Electrophoretic heterogeneity of polypeptide chains of specific antibodies. Science 1966; 152: 1253–5
- Huttunen J K, Lansimies E, Voutilainen E, et al. Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special reference to serum high-density lipoproteins. Circulation 1979; 60: 1220–9
- Kostner G. Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanionic precipitation. Clin Chem 1976; 22: 695
- Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–5